TY  - GEN
AU  - Hudson,Melissa M
AU  - Krasin,Matthew
AU  - Link,Michael P
AU  - Donaldson,Sarah S
AU  - Billups,Catherine
AU  - Merchant,Thomas E
AU  - Kun,Larry
AU  - Billet,Amy L
AU  - Kaste,Sue
AU  - Tarbell,Nancy J
AU  - Howard,Scott
AU  - Friedmann,Alison M
AU  - Hurwitz,Craig A
AU  - Young,Jeffrey A
AU  - Marcus,Karen C
AU  - Rai,Shesh
AU  - Cowan,Traci
AU  - Weinstein,Howard J
TI  - Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease
SN  - 0732-183X
PY  - 2004///1208
KW  - Adolescent
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Child
KW  - Child, Preschool
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Female
KW  - Hodgkin Disease
KW  - drug therapy
KW  - Humans
KW  - Male
KW  - Methotrexate
KW  - Prednisone
KW  - Procarbazine
KW  - Prognosis
KW  - Risk Assessment
KW  - Treatment Outcome
KW  - Vinblastine
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1200/JCO.2004.02.139
ER  -